M. Fraunholz and B. Sinha, Intracellular Staphylococcus aureus: live-in and let die, Cell Infect Microbiol, vol.2, p.43, 2012.

M. Revest, C. Jacqueline, and R. Boudjemaa, New in vitro and in vivo models to 5 evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection, J 6 Antimicrob Chemother, vol.71, pp.1291-1300, 2016.

J. L. Crandon, J. L. Kuti, and D. P. Nicolau, Comparative efficacies of human simulated exposures 8 of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a 9 range of vancomycin MICs in a murine pneumonia model, Antimicrob Agents Chemother, vol.10, pp.5115-5124, 2010.

P. K. Dandekar, P. R. Tessier, and P. Williams, Pharmacodynamic profile of daptomycin 12 against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine 13 thigh infection model, J Antimicrob Chemother, vol.52, pp.405-416, 2003.

J. Yu, J. Wu, and K. P. Francis, Monitoring in vivo fitness of rifampicin-resistant 15

, Staphylococcus aureus mutants in a mouse biofilm infection model, J Antimicrob Chemother, vol.16, pp.528-562, 2005.

W. Abdelhady, A. S. Bayer, and K. Seidl, Impact of vancomycin on sarA-mediated biofilm 18 formation: role in persistent endovascular infections due to methicillin-resistant 19 Staphylococcus aureus, J Infect, vol.209, pp.1231-1271, 2014.

T. Bjarnsholt, M. Alhede, and M. Alhede, The in vivo biofilm, Trends Microbiol, vol.21, pp.466-74, 2013.

K. Nishitani, W. Sutipornpalangkul, . De-mesy, and K. L. Bentley, Quantifying the natural 23 history of biofilm formation in vivo during the establishment of chronic implant, p.24

, Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors, J 25 Orthop Res, vol.33, pp.1311-1320, 2015.

C. E. Edmiston, M. P. Goheen, and G. R. Seabrook, Impact of selective antimicrobial 27 agents on staphylococcal adherence to biomedical devices, Am J Surg, vol.192, p.10, 2006.

E. Senneville, D. Joulie, and L. Legout, Outcome and predictors of treatment failure in 29 total hip/knee prosthetic joint infections due to Staphylococcus aureus, Antimicrob Agents Chemother, vol.30, p.12, 2009.

O. Murillo, C. Garrigos, and M. E. Pachon, Efficacy of high doses of daptomycin versus 34 alternative therapies against experimental foreign-body infection by methicillin-resistant 35 Staphylococcus aureus, Antimicrob Agents Chemother, vol.53, pp.4252-4259, 2009.

K. Smith, A. Perez, and G. Ramage, Comparison of biofilm-associated cell survival 37 following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the 38 antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin, Int J Antimicrob 39 Agents, vol.33, pp.374-382, 2009.

M. Lefebvre, C. Jacqueline, and G. Amador, Efficacy of daptomycin combined with 41 rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus 42 (MRSA) acute osteomyelitis, Int J Antimicrob Agents, vol.36, p.15, 2010.

R. Boudjemaa, R. Briandet, and M. Revest, New insight into daptomycin bioavailability 44 and localization in Staphylococcus aureus biofilms by dynamic fluorescence imaging

, Antimicrob Agents Chemother, vol.60, pp.4983-90, 2016.

F. Valour, J. P. Rasigade, and S. Trouillet-assant, Delta-toxin production deficiency in 1 Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with 2 osteoblast invasion and biofilm formation, Staphylococcus aureus Biofilms Induce, vol.21, pp.568-569, 2015.

, Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin. mBio, vol.6, p.18, 2015.

O. Cirioni, F. Mocchegiani, and R. Ghiselli, Daptomycin and rifampin alone and in 6 combination prevent vascular graft biofilm formation and emergence of antibiotic resistance 7 in a subcutaneous rat pouch model of staphylococcal infection, Eur J Vasc Endovasc, vol.8, pp.817-839, 2010.

L. Jones, B. D. Braithwaite, and B. Davies, Mechanism of late prosthetic vascular graft 10 infection, Cardiovasc Surg, vol.5, pp.486-495, 1997.